Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.
MRI
PI-RADS
Prostate cancer
TRUS
Journal
European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
12
03
2018
accepted:
29
05
2018
pubmed:
18
6
2018
medline:
23
7
2019
entrez:
18
6
2018
Statut:
ppublish
Résumé
The Prostate Imaging-Reporting and Data System (PI-RADS) v2 analysis system for multiparametric magnetic resonance imaging (mpMRI) detection of prostate cancer (PCa) is based on PI-RADS v1, accumulated scientific evidence, and expert consensus opinion. To summarize the accuracy, strengths and weaknesses of PI-RADS v2, discuss pathway implications of its use and outline opportunities for improvements and future developments. For this consensus expert opinion from the PI-RADS steering committee, clinical studies, systematic reviews, and professional guidelines for mpMRI PCa detection were evaluated. We focused on the performance characteristics of PI-RADS v2, comparing data to systems based on clinicoradiologic Likert scales and non-PI-RADS v2 imaging only. Evidence selections were based on high-quality, prospective, histologically verified data, with minimal patient selection and verifications biases. It has been shown that the test performance of PI-RADS v2 in research and clinical practice retains higher accuracy over systematic transrectal ultrasound (TRUS) biopsies for PCa diagnosis. PI-RADS v2 fails to detect all cancers but does detect the majority of tumors capable of causing patient harm, which should not be missed. Test performance depends on the definition and prevalence of clinically significant disease. Good performance can be attained in practice when the quality of the diagnostic process can be assured, together with joint working of robustly trained radiologists and urologists, conducting biopsy procedures within multidisciplinary teams. It has been shown that the test performance of PI-RADS v2 in research and clinical practice is improved, retaining higher accuracy over systematic TRUS biopsies for PCa diagnosis. Multiparametric magnetic resonance imaging (MRI) and MRI-directed biopsies using the Prostate Imaging-Reporting and Data System improves the detection of prostate cancers likely to cause harm, and at the same time decreases the detection of disease that does not lead to harms if left untreated. The keys to success are high-quality imaging, reporting, and biopsies by radiologists and urologists working together in multidisciplinary teams.
Identifiants
pubmed: 29908876
pii: S0302-2838(18)30424-X
doi: 10.1016/j.eururo.2018.05.035
pmc: PMC6292742
mid: NIHMS976621
pii:
doi:
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
385-396Subventions
Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States
Organisme : NIH HHS
ID : Z99 CA999999
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.
Références
Health Technol Assess. 2013 May;17(20):vii-xix, 1-281
pubmed: 23697373
Radiology. 2016 Sep;280(3):793-804
pubmed: 27035179
Eur Radiol. 2017 Dec;27(12):5204-5214
pubmed: 28656462
Sci Transl Med. 2012 Mar 28;4(127):127rv3
pubmed: 22461644
Eur Urol. 2017 Aug;72(2):282-288
pubmed: 27574821
J Magn Reson Imaging. 2017 Feb;45(2):579-585
pubmed: 27391860
BJU Int. 2011 May;107(9):1411-8
pubmed: 21044250
Lancet Oncol. 2015 Apr;16(4):417-25
pubmed: 25743937
Eur Radiol. 2016 Oct;26(10):3580-7
pubmed: 26847042
Eur Urol. 2017 Apr;71(4):648-655
pubmed: 27349615
Radiology. 2017 Dec;285(3):859-869
pubmed: 28727501
Radiology. 2018 Jan;286(1):186-195
pubmed: 29053402
Eur Urol. 2017 Feb 28;:null
pubmed: 28258784
BJU Int. 2018 Jul;122(1):40-49
pubmed: 29024425
Cancer Imaging. 2011 Oct 03;11 Spec No A:S27-37
pubmed: 22187067
AJR Am J Roentgenol. 2017 May;208(5):1058-1063
pubmed: 28225639
Eur Urol. 2016 Jan;69(1):41-9
pubmed: 26361169
BJU Int. 2016 Jan;117(1):80-6
pubmed: 25099182
Eur Urol. 2014 Sep;66(3):430-6
pubmed: 24377803
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
AJR Am J Roentgenol. 2011 Nov;197(5):W876-81
pubmed: 22021535
J Urol. 2013 Aug;190(2):509-14
pubmed: 23416641
Eur Radiol. 2016 Jun;26(6):1606-12
pubmed: 26396111
Radiology. 2012 Mar;262(3):894-902
pubmed: 22357889
BJU Int. 2017 Feb;119(2):225-233
pubmed: 26935594
Eur Urol. 2015 Mar;67(3):569-76
pubmed: 25257029
J Magn Reson Imaging. 2018 Nov;48(5):1326-1335
pubmed: 29603833
Eur Radiol. 2012 Apr;22(4):746-57
pubmed: 22322308
PLoS One. 2016 Dec 29;11(12):e0169120
pubmed: 28033423
Acad Radiol. 2017 Sep;24(9):1101-1106
pubmed: 28546032
J Urol. 2017 Sep;198(3):583-590
pubmed: 28373133
Eur Urol. 2017 Aug;72(2):250-266
pubmed: 28336078
Eur Urol. 2017 Dec;72(6):888-896
pubmed: 28400169
Int J Clin Oncol. 2017 Apr;22(2):214-221
pubmed: 27730440
J Urol. 2018 May;199(5):1182-1187
pubmed: 29175542
Eur Radiol. 2017 May;27(5):2095-2109
pubmed: 27491874
J Urol. 2011 Nov;186(5):1818-24
pubmed: 21944089
BJU Int. 2013 Sep;112(5):568-77
pubmed: 23773772
Urology. 2018 Feb;112:112-120
pubmed: 29155186
Eur Radiol. 2016 Apr;26(4):1098-107
pubmed: 26135002
BJU Int. 2011 Oct;108(8 Pt 2):E171-8
pubmed: 21426475
Eur Urol Focus. 2019 Jul;5(4):592-599
pubmed: 29226826
Acad Radiol. 2018 Feb;25(2):188-195
pubmed: 29107458
J Magn Reson Imaging. 2013 Jun;37(6):1392-401
pubmed: 23172614
Eur J Radiol. 2017 Aug;93:9-15
pubmed: 28668436
JAMA Oncol. 2018 May 1;4(5):678-685
pubmed: 29470570
J Urol. 2017 Aug;198(2):316-321
pubmed: 28163032
BMJ Open. 2014 Jun 15;4(6):e004895
pubmed: 24934207
Eur Urol. 2016 Dec;70(6):954-960
pubmed: 27329565
Cancer. 2016 Mar 15;122(6):884-92
pubmed: 26749141
N Engl J Med. 2016 Oct 13;375(15):1415-1424
pubmed: 27626136
Radiology. 2017 Oct;285(1):157-166
pubmed: 28514203
BJU Int. 2012 Apr;109(8):1170-6
pubmed: 21854535
J Urol. 2017 Feb;197(2):327-334
pubmed: 27582434
Eur Urol. 2013 Dec;64(6):876-92
pubmed: 23787356
J Urol. 2018 Apr;199(4):976-982
pubmed: 29154904
Eur Urol. 2011 Apr;59(4):477-94
pubmed: 21195536
AJR Am J Roentgenol. 2018 Jan;210(1):101-107
pubmed: 29064758
Eur Urol. 2015 Feb;67(2):233-8
pubmed: 24993868
J Urol. 2016 Dec;196(6):1613-1618
pubmed: 27320841
Eur Urol. 2012 May;61(5):1019-24
pubmed: 22336380
N Engl J Med. 2017 Jul 13;377(2):132-142
pubmed: 28700844
J Urol. 2013 Oct;190(4):1218-22
pubmed: 23643603
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
Cell Oncol (Dordr). 2016 Apr;39(2):97-106
pubmed: 26790878
Urol Oncol. 2015 Jun;33(6):266.e9-16
pubmed: 25858102
J Urol. 2012 Sep;188(3):762-7
pubmed: 22818143
Eur Urol. 2015 Jul;68(1):8-19
pubmed: 25454618
Eur Urol. 2016 Mar;69(3):419-25
pubmed: 26033153
J Urol. 2012 Jun;187(6):2032-8
pubmed: 22498205
Eur Urol. 2014 Jul;66(1):22-9
pubmed: 24666839
BMC Cancer. 2016 Oct 21;16(1):816
pubmed: 27769214
Eur Urol. 2015 Sep;68(3):438-50
pubmed: 25480312
AJR Am J Roentgenol. 2017 Sep;209(3):W145-W151
pubmed: 28657843
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
JAMA. 2015 Jan 27;313(4):390-7
pubmed: 25626035
Eur Urol. 2018 Jan;73(1):23-30
pubmed: 28935163
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720
pubmed: 23440794
Eur Urol. 2018 Apr;73(4):572-582
pubmed: 29129398
AJR Am J Roentgenol. 2017 Jul;209(1):W1-W9
pubmed: 28418690
Am J Clin Oncol. 2013 Apr;36(2):116-20
pubmed: 22307210
Curr Opin Urol. 2015 Nov;25(6):522-35
pubmed: 26375060
Eur Urol. 2013 Oct;64(4):544-52
pubmed: 23537686
Radiology. 2003 Nov;229(2):409-14
pubmed: 12970464
Eur Urol. 2017 Aug;72(2):177-188
pubmed: 28196723
Urol Oncol. 2015 Jan;33(1):17.e1-17.e7
pubmed: 25443268
Transl Androl Urol. 2017 Jun;6(3):432-443
pubmed: 28725585
J Clin Oncol. 2015 Jan 20;33(3):272-7
pubmed: 25512465
Eur Urol. 2015 Jun;67(6):1112-1121
pubmed: 25466942
Eur Urol. 2016 Jun;69(6):1129-34
pubmed: 26651990
Eur Urol. 2017 Apr;71(4):517-531
pubmed: 27568655
BJU Int. 2018 Jul;122(1):13-25
pubmed: 29699001
Eur Radiol. 2013 Jul;23(7):2019-29
pubmed: 23494494
J Magn Reson Imaging. 2013 Jan;37(1):48-58
pubmed: 22566285
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566